Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NowPatient vs Rejuve Meds

NowPatient
Graded #217

Lower grade

vs+0.5999999999999943
Rejuve Meds
Graded #208

Higher grade

The verdict

Rejuve Meds takes it — 66.1/100 to 65.5/100, but only just.

Rejuve Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no… NowPatient is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRejuve Meds +30
35
65
Dose & formulationNowPatient +29
93
64
Clinical oversightNowPatient +7
86
79
Labs & monitoringNowPatient +2
54
52
FulfillmentRejuve Meds +1
70
71
Contract termsRejuve Meds +6
55
61
NowPatient · left barRejuve Meds · right bar

The numbers

MetricNowPatientRejuve Meds
WeighScore65.5/10066.1/100
GradeCC
Scorecard rank#217#208
Semaglutide$1,349/mo (brand Wegovy)$165/mo (starting dose, compounded)
Tirzepatide$1,069/mo (brand Mounjaro, promotional rate)$265/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
NowPatient

Graded #217 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)
Rejuve Meds

Graded #208 · C

Strengths

  • Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
  • No membership fees — everything is included; free shipping
  • HSA/FSA eligible; intro pricing from $85 for the first month
  • Doctor-guided programs with personalized care
  • Names a "Rejuve Meds Pharmacy Network" for fulfillment

Where it loses points

  • Individual compounding pharmacies not named (only a "pharmacy network")
  • Prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard